Chem. J. Chinese Universities ›› 2005, Vol. 26 ›› Issue (5): 860.

• Articles • Previous Articles     Next Articles

An Efficient Approach to the Synthesis of Spiro-cyclopropane Derivatives Utilizing 4-Methoxy-2-bromobutyrolactone

YU Zhao-Lian, LI Sen-Lan, GUO Jin-Bo, CHEN Qing-Hua   

  1. Department of Chemistry, Luoyang Normal College, Luoyang 470022, China
  • Received:2004-06-13 Online:2005-05-10 Published:2005-05-10

Abstract: Cyclopropane-containing natural products have received considerable attention as the synthetic targets due to their significant effects on bioactivities with concomitant medical and agricultural implications. We recently reported a valuable synthetic route to spiro-cyclopropane-butinolied derivatives containing multiple stereogenic centers, using 5-L-menthyloxy-3-bromo-2(5H)-furanone, and different nucleophiles by tandem double Michael addition/internal nucleophilic substitution. On the basis of the previous work, the synthesis of 4-methoxy-2-bromobutyrolactone (4) was conveniently achieved from 4-hydroxybutyrolactone (2) as a starting material through the acetalization of methanol. 2-Bromobutyrolactone (4) as a synthon reacts with various nucleophiles under mild conditions to form the diversely functionalized spiro-cyclopropane derivatives 8a—8d via tandem double Michael addition/intramolecular nucleophilic substitution. Spiro-cyclopropane compounds 8a—8d were identified on the basis of their elemental analysis and spectroscopic data, such as IR, 1H NMR, 13C NMR and MS. The stereochemistry and configuration of the spiro-cyclopropane compound 8d was measured by X-ray crystallography. This result provides an efficient synthetic route to the interesting functionalized target molecules 8 with 4-methoxy-2-bromobutyrolactone (4) as a cheap substrate. It could be furnished further an important synthetic strategy for some complex cyclic natural and nonnatural products.

Key words: 4-Methoxy-2-bromobutyrolactone, Tandem reaction, Spiro-cyclopropane derivatives, (X-ray) crystallography determination

CLC Number: 

TrendMD: